Question 1

What are the potential benefits of using levetiracetam for my newborn?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dosing of Levetiracetam (Keppra) in Neonates clinical trial (NCT01239212). Contact the study team or your healthcare provider for specific answers.

Question 2

How will you monitor my infant's response to the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dosing of Levetiracetam (Keppra) in Neonates clinical trial (NCT01239212). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dosing of Levetiracetam (Keppra) in Neonates clinical trial (NCT01239212). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there alternative treatments available for my baby's seizures?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dosing of Levetiracetam (Keppra) in Neonates clinical trial (NCT01239212). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my infant does not qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dosing of Levetiracetam (Keppra) in Neonates clinical trial (NCT01239212). Contact the study team or your healthcare provider for specific answers.

What this study is about